| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 06/09/2005 | WO2005052141A1 Inhibition of stem cell differentiation, enhancement of proliferation and selective induction of apoptosis by wnt factors |
| 06/09/2005 | WO2005052140A2 Multipotent postnatal stem cells from human periodontal ligament and uses thereof |
| 06/09/2005 | WO2005052139A2 Method of inducing memory b cell development and terminal differentiation |
| 06/09/2005 | WO2005052137A1 Tangential flow filtration devices and methods for stem cell enrichment |
| 06/09/2005 | WO2005052115A2 Use of parasitic biological agents for diseases prevention and control |
| 06/09/2005 | WO2005051927A1 Method of culturing cd4-positive t cells via stimulation culture of hiv-1-infected pheripheral monocytes and hiv-1 growth inhibitor |
| 06/09/2005 | WO2005051433A1 Method for treating human tumor cells with a newcastle disease virus strain and a chemotherapeutic agent |
| 06/09/2005 | WO2005051412A2 Regulation of sperm function |
| 06/09/2005 | WO2005051408A1 Method for preventing and treating diabetes using dg119 |
| 06/09/2005 | WO2005051330A2 METHOD FOR TREATING HUMAN TUMOR CELLS WITH A NEWCASTLE DISEASE VIRUS STRAIN HAVING A p53 INDEPENDENT ONCOLYTIC EFFECT |
| 06/09/2005 | WO2005034843A3 Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
| 06/09/2005 | WO2005030939A3 Method and composition for regulating expansion of stem cells |
| 06/09/2005 | WO2005007175A3 Cadherin directed molecular and cellular localization |
| 06/09/2005 | WO2005003335A3 Rapamycin resistant t cells and therapeutic uses thereof |
| 06/09/2005 | WO2005000344A3 Method for identification of tr1 lymphocytes regulators by the presence and overexpression of specific molecules and application thereof |
| 06/09/2005 | WO2004082614A3 Methods for treating cancer using perna canaliculus component(s) and extracts of perna canaliculus |
| 06/09/2005 | WO2004071283A3 Use of umbilical cord blood to treat individuals having a disease, disorder or condition |
| 06/09/2005 | WO2003084302A3 Anti-aging agent |
| 06/09/2005 | US20050125848 Method of isolating human neuroepithelial precursor cells from human fetal tissue |
| 06/09/2005 | US20050125846 Expression vector comprising nucleotide sequences coding transmembrant transport protein for use in diagnosis, treatment and prevention of thyroid disorders |
| 06/09/2005 | US20050124927 Blood processing systems and methods that alternate flow of blood component and additive solution through an in-line leukofilter |
| 06/09/2005 | US20050124796 Mouse cytokine receptor |
| 06/09/2005 | US20050124703 Polycosanols from Ericerus pela wax |
| 06/09/2005 | US20050124576 Administering by mouth to dogs and cats an antiinflammatory agent for gastrointestinal disorders, particularly as a antidiarrhetic agent, an effective mixture of glutamine (>0.1 % weight), frmentable fiber(s0 (>0.5 %), antioxidant(s) (>0.1 %) and omega-3 fatty acid(s) (>0.1%); gastritis, enteritis |
| 06/09/2005 | US20050124571 Exposure a suspension of active agents such as viral vector and microparticles to condition which results in greater efficiency; injecting mixture, then removal of microparticles |
| 06/09/2005 | US20050124538 for prophylaxis, prevention, treatment or therapy of inflammatory conditions or allergic reactions in a mammal; binds bacterial lipopeptide |
| 06/09/2005 | US20050124068 Hepatocellular carcinoma specific promoter and uses thereof |
| 06/09/2005 | US20050124034 Preparing preferential peptide from fish skin via salt water cleansing, proteolytic digestion, activated carbon concentration and drying; for use in food and medicine supplements |
| 06/09/2005 | US20050124007 Human mesencephalon cell lines and methods of use therefor |
| 06/09/2005 | US20050124003 Using immunoaffinity selection to isolate and propagate pluripotent stem cell populations from fetal developmental tissues; cell replacement therapies |
| 06/09/2005 | US20050123634 Method for modulating steroidogenic activity |
| 06/09/2005 | US20050123619 mixture of dimethyl sulfoxide, stearic acid, emulsifying wax, glycerine, emu oil, sal butter, glucosamine, coconut oil, white beeswax, active calendula oil, slippery elm oil, chamomile oil, arnica oil, valenrian oil, peppermint oil, grapefruit seed extract, lavender oil and distilled water |
| 06/09/2005 | US20050123603 Oral delivery vehicle; food products |
| 06/09/2005 | US20050123587 Fluid composition for increased total water intake |
| 06/09/2005 | US20050123541 Anti-TNF antibodies, compositions, methods and uses |
| 06/09/2005 | US20050123529 Systems and methods related to degradation of uremic toxins |
| 06/09/2005 | US20050123525 Composition and method for inducing immune tolerance towards cell, tissue and/or organ transplants |
| 06/09/2005 | US20050123524 Pharmaceutical compositions and methods for treating neuronal damages and neurodegenerative diseases |
| 06/09/2005 | US20050123522 Monocyte-derived dendritic cell subsets |
| 06/09/2005 | US20050123521 Immortalization of human cells by the ectopic expression of human telomerase reverse transcriptase |
| 06/09/2005 | US20050123513 Use of a reovirus for the manufacture of a medicament for treating a Ras-mediated neoplasm; administering reovirus to a Ras-mediated neoplasm without the side effects associated with other forms of cancer therapy; anticancer |
| 06/09/2005 | US20050123510 attenuated DNA viruses which increases production of chemokines |
| 06/09/2005 | US20050123479 bioassays for screening antiinflammatory agents used for treating or ameliorating the symptoms of T-cell, macrophage or neutrophil mediated diseases in mammals |
| 06/09/2005 | DE10342104A1 Verfahren zur Herstellung eines Mittels zur Wundbehandlung und nach diesem Verfahren hergestelltes Mittel A process for the preparation of an agent for wound treatment, and produced according to this method means |
| 06/09/2005 | CA2546775A1 A system for plasmid maintenance comprising a cell growth inhibiting chromosomal gene and a plasmid encoding antisense sequence |
| 06/09/2005 | CA2546760A1 Multipotent postnatal stem cells from human periodontal ligament and uses thereof |
| 06/09/2005 | CA2546703A1 Regulation of sperm function |
| 06/09/2005 | CA2546416A1 Use of parasitic biological agents for diseases prevention and control |
| 06/09/2005 | CA2546349A1 Tangential flow filtration devices and methods for stem cell enrichment |
| 06/09/2005 | CA2545520A1 Inhibition of stem cell differentiation, enhancement of proliferation and selective induction of apoptosis by wnt factors |
| 06/08/2005 | EP1538202A2 Production of human alpha-galactosidase A |
| 06/08/2005 | EP1538198A2 Lactic acid bacteria and their cellular components inducing immunoregulatory function, and method of obtaining the same |
| 06/08/2005 | EP1537878A1 Immunopotentiating compositions |
| 06/08/2005 | EP1537873A1 The pharmaceutical formulation of traditional chinese medicine for abstinence of drug and preparation method and use thereof |
| 06/08/2005 | EP1537872A1 Immunostimulator having antineoplastic action and method for producing said immunostimulator |
| 06/08/2005 | EP1537417A2 Method of diagnosing colon and gastric cancers |
| 06/08/2005 | EP1537219A2 Activation of tumor-reactive lymphocytes via antibodies or genes recognizing cd3 or 4-1bb |
| 06/08/2005 | EP1537206A2 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 06/08/2005 | EP1537204A2 Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells |
| 06/08/2005 | EP1537203A1 USE OF DENDRITIC CELLS (DCs) EXPRESSING INTERLEUKIN 12 (IL-12) |
| 06/08/2005 | EP1537137A2 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 06/08/2005 | EP1536837A1 Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors |
| 06/08/2005 | EP1536816A2 Amelioration of effects of cigarette smoke |
| 06/08/2005 | EP1536807A2 Non-polymeric hematopoietic cell clots for delivery of active agents |
| 06/08/2005 | EP1536688A2 Mammalian megakaryocyte progenitor cell |
| 06/08/2005 | EP1169441B1 Pharmaceutical compositions for the treatment of heart failure |
| 06/08/2005 | EP0882463B1 Adsorbent for immunoglobulins and complexes thereof and adsorption device |
| 06/08/2005 | CN1625345A Vital cell preparations containing lactic acid bacterium as the ative ingredient and food containing lactic acid |
| 06/08/2005 | CN1624126A Ret ligand (retl) for stimulating neural and renal growth |
| 06/08/2005 | CN1623563A Traditional Chinese medicinal compocition for treating pancreatitis, cholecystitis, appendicitis and acute and chronic gastro enteritis |
| 06/08/2005 | CN1623562A Active calcium and its production method |
| 06/08/2005 | CN1204914C Medicine for preventing and treating intestinal adhesion in abdominal operation, and preparing method thereof |
| 06/08/2005 | CN1204908C Chinese medicine for treating deafness and tinnitus and its prepn method |
| 06/08/2005 | CN1204900C Chinese patent drug for treating prostate proliferation and hypertrophy |
| 06/08/2005 | CN1204899C Chinese medicine (instant particles) for treating intractable tined and its preparing process |
| 06/07/2005 | US6902932 Helically organized silk fibroin fiber bundles for matrices in tissue engineering |
| 06/07/2005 | CA2222482C Non-virulent mycoplasma synoviae and vaccine thereof |
| 06/07/2005 | CA2091789C Method of inhibiting microvascular thrombosis |
| 06/05/2005 | CA2449186A1 Generation of therapeutic regulatory dc by multiple gene silencing through induction of rna interference |
| 06/02/2005 | WO2005050215A1 Selection of lactic acid bacteria enhancing the immune response against streptococcus pneumoniae |
| 06/02/2005 | WO2005049845A2 Oncolytic herpes simplex virus encoding a heterologous nitroreductase |
| 06/02/2005 | WO2005049844A2 Vectors, mutant viruses and methods for generating mutant viruses |
| 06/02/2005 | WO2005049822A1 Method of growing myocardial cells |
| 06/02/2005 | WO2005049813A1 Isolated phages and their use as disinfectant in food or for sanitation of factory environment |
| 06/02/2005 | WO2005049810A1 Skeletal muscle-derived cells and methods related thereto |
| 06/02/2005 | WO2005049786A2 Modulation of angiogenesis by bartonella henselae |
| 06/02/2005 | WO2005049647A2 Compositions comprising melittin-derved peptides and methods for the potentiation of immune responses against target antigens |
| 06/02/2005 | WO2005049094A1 A mixed complementary viral vector for gene therapy |
| 06/02/2005 | WO2005049077A2 Avian vaccine effective against infectious bursal disease virus |
| 06/02/2005 | WO2005049072A2 Therapeutic cancer vaccine with fragments of trag-3 |
| 06/02/2005 | WO2005049056A2 Immune modulator comprising whole cell rhodococcus, gordonia, nocardia, dietzia, tsukamurella or nocardioides bacteria |
| 06/02/2005 | WO2005049055A1 Autologous treatment of degenerated disc with cells |
| 06/02/2005 | WO2005049054A1 Compositions and methods for the treatment of skin damage |
| 06/02/2005 | WO2005048957A2 Novel insertion sites in pox vectors |
| 06/02/2005 | WO2005048714A1 Fluid composition for increased total water intake |
| 06/02/2005 | WO2005017115A3 Cord blood-derived hematopoietic progenitor cells |
| 06/02/2005 | WO2005016245A3 Compounds having inhibitive activity of phosphatidylinositol 3-kinase and methods of use thereof |
| 06/02/2005 | WO2005005637A3 Herpes simplex virus comprising a genetically modified glycoprotein d |
| 06/02/2005 | WO2005003333A3 Use of umbilical cord blood stem cells for preventing brain damage due to lack of oxygen and providing neuroprotection |
| 06/02/2005 | WO2004071414A3 Therapeutic anti-hcv (al9) compounds |